Zhenhao Duan is a researcher affiliated with Peking University in China, whose work primarily lies within the field of Medicine, with a significant focus on Infectious Diseases, Microbiology, and Molecular Biology. Their scholarly output includes numerous publications related to viral infections, antimicrobial activities, and computational methods in drug discovery.
The recent papers authored or co-authored by Zhenhao Duan cover key developments in SARS-CoV-2 and COVID-19 research. These include studies such as "SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model" (2021, Science), "SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target" (2021, Cell Research), "Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models" (2020, Cell Research), "Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system" (2023, Nature Biomedical Engineering), and "Transferrin receptor is another receptor for SARS-CoV-2 entry" (2020, bioRxiv (Cold Spring Harbor Laboratory)).
The topics they explore are varied but consistently related to virology and infectious disease dynamics. These topics include:
Zhenhao Duan collaborates frequently with several researchers, indicative of a collaborative research network. Frequently listed co-authors include Ren Lai, Zhiye Zhang, Lin Jin, Peter Muiruri Kamau, and Zhiyi Liao.
The primary venues where Zhenhao Duan publishes research are specialized journals known for their focus on molecular and biomedical research fields. These publication venues include:
Zhenhao Duan's subfields of study further specify their scientific concentration:
Their research incorporates investigations into both fundamental molecular mechanisms and clinical applications concerning infectious agents, with a particular interest in the pathophysiology of SARS-CoV-2. This combination of research areas situates Zhenhao Duan within the contemporary global effort to understand and mitigate COVID-19 and related viral diseases through multidisciplinary approaches.
Zhenhao Duan;Zhenhao Duan;Rui Sun
Zhenhao Duan;Rui Sun;Chen Zhu;I-Ming Chou
Zhenhao Duan;Nancy Møller;John H Weare
Zhenhao Duan;Shide Mao
Zhenhao Duan;Nancy Møller;Jerry Greenberg;John H. Weare
Zhenhao Duan;Nancy Møller;John H. Weare
Zhenhao Duan;Nancy Møller;John H Weare
Zhenhao Duan;Nancy Møller;John H. Weare
Zhigang Zhang;Zhenhao Duan
Rui Sun;Zhenhao Duan;Zhenhao Duan
Chi Zhang;Zhenhao Duan
Zhenhao Duan;Zhigang Zhang
Zhenhao Duan;Dedong Li
Dedong Li;Zhenhao Duan
Zhenhao Duan;Rui Sun;Rong Liu;Chen Zhu
Ming Geng;Zhenhao Duan
Zhenhao Duan;Jiawen Hu;Dedong Li;Shide Mao
Junfeng Qin;Robert J. Rosenbauer;Zhenhao Duan
Rui Sun;Zhenhao Duan
Jiawen Hu;Zhenhao Duan;Chen Zhu;I-Ming Chou
If you think any of the details on this page are incorrect, let us know.
Texas A&M University
University of the Free State
National Botanical Research Institute
University of Melbourne
Spanish National Research Council
Columbia University
University of Michigan–Ann Arbor
Johns Hopkins University School of Medicine
University of Maryland, College Park
University of Siena
Queen's University
University of Helsinki
Liverpool School of Tropical Medicine
Lund University
University of Graz
Utrecht University
